Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna L McNaughton

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Journal of Virology|April 12, 2022
Spacer Domain in Hepatitis B Virus Polymerase: Plugging a Hole or Performing a Role?Caitlin Pley, José Lourenço, Anna L McNaughton, et al.
Nature Reviews. Gastroenterology & Hepatology|December 16, 2020
Extending treatment eligibility for chronic hepatitis B virus infectionAnna L McNaughton, Maud Lemoine, Christo van Rensburg, et al.
BMJ Global Health|January 6, 2021
The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infectionCaitlin M Pley, Anna L McNaughton, Philippa C Matthews, et al.
Journal of Viral Hepatitis|December 11, 2020
Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysisCori Campbell, Tingyan Wang, Anna L McNaughton, et al.
Virus Evolution|January 11, 2023
Polymorphisms predicting phylogeny in hepatitis B virusJosé Lourenço, Anna L McNaughton, Caitlin Pley, et al.
The Journal of General Virology|March 6, 2020
Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequencesAnna L McNaughton, Peter A Revill, Margaret Littlejohn, et al.
Frontiers in Immunology|August 1, 2018
Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and PathogenSheila F Lumley, Anna L McNaughton, Paul Klenerman, et al.
Hepatology (Baltimore, Md.)|June 8, 2013
Mixed genotype hepatitis C infections and implications for treatmentAnna L McNaughton, Emma C Thomson, Kate Templeton, et al.
The Lancet. HIV|December 4, 2024
HIV incidence and factors associated with HIV risk among people who inject drugs engaged with harm-reduction programmes in four provinces in South Africa: a retrospective cohort studyAdelina Artenie, Rachel Perry, Memory Mahaso, et al.
Wellcome Open Research|December 4, 2018
A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic reviewJolynne Mokaya, Anna L McNaughton, Lela Burbridge, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Journal of Virology|April 12, 2022
Spacer Domain in Hepatitis B Virus Polymerase: Plugging a Hole or Performing a Role?Caitlin Pley, José Lourenço, Anna L McNaughton, et al.
Nature Reviews. Gastroenterology & Hepatology|December 16, 2020
Extending treatment eligibility for chronic hepatitis B virus infectionAnna L McNaughton, Maud Lemoine, Christo van Rensburg, et al.
BMJ Global Health|January 6, 2021
The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infectionCaitlin M Pley, Anna L McNaughton, Philippa C Matthews, et al.
Journal of Viral Hepatitis|December 11, 2020
Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta-analysisCori Campbell, Tingyan Wang, Anna L McNaughton, et al.
Virus Evolution|January 11, 2023
Polymorphisms predicting phylogeny in hepatitis B virusJosé Lourenço, Anna L McNaughton, Caitlin Pley, et al.
The Journal of General Virology|March 6, 2020
Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequencesAnna L McNaughton, Peter A Revill, Margaret Littlejohn, et al.
Frontiers in Immunology|August 1, 2018
Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and PathogenSheila F Lumley, Anna L McNaughton, Paul Klenerman, et al.
Hepatology (Baltimore, Md.)|June 8, 2013
Mixed genotype hepatitis C infections and implications for treatmentAnna L McNaughton, Emma C Thomson, Kate Templeton, et al.
The Lancet. HIV|December 4, 2024
HIV incidence and factors associated with HIV risk among people who inject drugs engaged with harm-reduction programmes in four provinces in South Africa: a retrospective cohort studyAdelina Artenie, Rachel Perry, Memory Mahaso, et al.
Wellcome Open Research|December 4, 2018
A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic reviewJolynne Mokaya, Anna L McNaughton, Lela Burbridge, et al.
Pageof 5